Skip to main content

Table 2 Clinicopathological characteristics statistics of patients from GSE13507

From: The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma

Clinicopathological Features CDCA3 expression level Total P value
Low High
Overall 90 75 165  
Gender    
 Female 15 (16.67%) 15 (20.00%) 30 0.5804
 Male 75 (83.33%) 60 (80.00%) 135
Grade     
 Low 76 (84.44%) 29 (38.67%) 105 < 0.001***
 High 14 (15.56%) 46 (62.33%) 60
Invasiveness     
 Muscle invasive 22 (22.44%) 40 (53.33%) 62 < 0.001***
 Non-muscle invasive 68 (77.56%) 35 (46.67%) 103
M stage     
 M0 86 (95.56%) 72 (96.00%) 158 0.8878
 M1 + MX 4 (4.44%) 3 (4.00%) 7
N stage     
 N0 86 (95.56%) 63 (84.00%) 149 0.0125*
 N1 + N2 + N3 + NX 4 (4.44%) 12 (16.00%) 16
Recurrence     
 Yes 22 (24.44%) 14 (18.67%) 36 0.3709
 No 68 (75.56%) 61 (81.33%) 129  
Progression     
 Yes 11 (12.22%) 20 (26.67%) 31 0.0180*
 No 79 (87.78%) 55 (73.33%) 134